Quest Diagnostics Inc(DGX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low206.55
Day High209.89
Open:207.97
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Tipranks
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Celldex (CLDX) and Mirum Pharmaceuticals (MIRM)
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
StockStory
3 Reasons to Sell DGX and 1 Stock to Buy Instead
DGX
Tipranks
Quest Diagnostics Shareholders Back Board, Pay and Auditor
StockStory
1 Profitable Stock to Own for Decades and 2 We Avoid
ROKU
Tipranks
Quest Diagnostics Issues $500 Million Senior Unsecured Notes
Zacks Investment Research
Bullish Quarterly Results: 3 Companies Raising Guidance
Bullish Quarterly Results: 3 Companies Raising Guidance
Tipranks
Quest Diagnostics Prices $500 Million Senior Notes Offering
Motley Fool
2026 Market Cap Madness Championship: Loren v. Emily
StockStory
5 Must-Read Analyst Questions From Quest’s Q1 Earnings Call
DGX
Tipranks
Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), Quest Diagnostics (DGX) and Merck & Company (MRK)
Tipranks
Barclays Sticks to Its Buy Rating for Quest Diagnostics (DGX)
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Aktis Oncology, Inc. (AKTS), Intuitive Surgical (ISRG)
Tipranks
Quest Diagnostics Lifts Outlook On Strong Earnings Call
The Globe and Mail
Market Factors: Global profit growth sours and why that’s important for all investors
Jeff Bezos at the main panel of Italian Tech Week 2025 REUTERS/Remo Casilli/File Photo
StockStory
DGX Q1 Deep Dive: Organic Growth, Consumer Testing Momentum, and Advanced Diagnostics Drive Outlook
DGX
Motley Fool
Quest (DGX) Q1 2026 Earnings Transcript
Tipranks
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Centessa Pharmaceuticals (CNTA) and Perspective Therapeutics (CATX)
StockStory
Quest’s (NYSE:DGX) Q1 CY2026 Sales Beat Estimates
DGX

Profile

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.